Biopharma Investor Tool

Headquarters country Select country Australia Austria Belgium Canada Chile Colombia Costa Rica Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Mexico Netherlands New Zealand Norway Poland Portugal Slovak Republic Slovenia Spain Sweden Switzerland Türkiye United Kingdom United States State / region Select region California Massachusetts New York England Ontario Bavaria Other Other region City Select city Boston San Francisco New York City London Toronto Other Other city Funding stage Select stage Pre-seed Seed Series A Series B Series C+ Growth Actively fundraising Unknown Yes No Industry / category Select category Life Sciences Biotech Medtech Digital Health Research Tools Healthcare Services

Primary category Select primary category Therapeutics Diagnostics Medical Devices Digital Health / Software Research Tools Biomanufacturing / CMC Development stage Select stage Discovery Preclinical IND-enabling Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Business model Select model Asset-centric Platform Tools / Services

Raising now Unknown Yes No Target round type Select round Seed Series A Series B Bridge Extension Investor type Select type Angel Micro-VC VC Strategic Partnerships Select partnership None Academic Pharma CRO / CDMO Other Revenue status Select status Pre-revenue Pilot Revenue Regulatory product type Select type SaMD Clinical Decision Support Digital Therapeutic Not a medical product Regulatory pathway Not specified 510(k) De Novo PMA Evidence type Select evidence In vitro In vivo Human data Real-world data ClinicalTrials.gov listed Unknown Yes No Clinical trial phase Select phase Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 IP status Select status Disclosure only Provisional PCT Granted Unknown University spinout Unknown Yes No Key investors Target / Pathway / MoA